Verition Fund Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-301,923
| Closed | -$39.8M | – | 3173 |
|
|
2025
Q1 | $39.8M | Buy |
301,923
+256,711
| +568% | +$33.9M | 0.19% | 45 |
|
|
2024
Q4 | $3.78M | Buy |
+45,212
| New | +$3.78M | 0.01% | 853 |
|
|
2024
Q3 | – | Sell |
-10,364
| Closed | -$710K | – | 2831 |
|
|
2024
Q2 | $710K | Buy |
10,364
+7,452
| +256% | +$510K | ﹤0.01% | 1300 |
|
|
2024
Q1 | $202K | Buy |
+2,912
| New | +$202K | ﹤0.01% | 1899 |
|
|
2023
Q4 | – | Sell |
-130,342
| Closed | -$6.79M | – | 2267 |
|
|
2023
Q3 | $6.79M | Buy |
130,342
+35,581
| +38% | +$1.85M | 0.08% | 298 |
|
|
2023
Q2 | $6M | Buy |
94,761
+9,022
| +11% | +$571K | 0.08% | 287 |
|
|
2023
Q1 | $4.64M | Buy |
85,739
+9,898
| +13% | +$536K | 0.06% | 355 |
|
|
2022
Q4 | $4.01M | Buy |
75,841
+6,485
| +9% | +$343K | 0.06% | 327 |
|
|
2022
Q3 | $3.23M | Sell |
69,356
-34,680
| -33% | -$1.61M | 0.04% | 542 |
|
|
2022
Q2 | $5.94M | Sell |
104,036
-72,765
| -41% | -$4.15M | 0.12% | 205 |
|
|
2022
Q1 | $10.8M | Buy |
176,801
+83,201
| +89% | +$5.09M | 0.13% | 101 |
|
|
2021
Q4 | $4.9M | Sell |
93,600
-2,840
| -3% | -$149K | 0.04% | 267 |
|
|
2021
Q3 | $3.6M | Buy |
96,440
+8,623
| +10% | +$321K | 0.03% | 264 |
|
|
2021
Q2 | $3.59M | Buy |
87,817
+20,360
| +30% | +$831K | 0.03% | 247 |
|
|
2021
Q1 | $2.29M | Hold |
67,457
| – | – | 0.03% | 303 |
|
|
2020
Q4 | $2.15M | Buy |
+67,457
| New | +$2.15M | 0.02% | 283 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1006 |
|
|
2019
Q4 | – | Sell |
-118,091
| Closed | -$882K | – | 1255 |
|
|
2019
Q3 | $882K | Buy |
+118,091
| New | +$882K | 0.02% | 353 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1312 |
|